ENDACEA’s leadership, along with its partners and shareholders, are accountable for the company’s continued research and development success. Since 1996, it has been committed to bringing more than 25 years of experience to discover and develop innovative treatments and medicines.
Dr. Wilson completed Pulmonary Medicine Post-Doctoral Research and Respiratory Intensive Care/Cardiology fellowships at Massachusetts General Hospital. She practiced medicine for 21 years before founding ENDACEA in 1995.
Dr. Wilson is a board-certified anesthesiologist and critical care physician scientist with vast expertise in cardiopulmonary medicine. She received her M.D degree from the University of Virginia and her B.S in Chemistry from Madison College.
Prior to September 2000, her name was Constance Fisher Neely.